Friday, January 9, 2009

Autophagy and tumor dormancy in human ovarian cancer cells

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells by Zhen Lu and 11 co-authors, including Robert C. Bast, Jr., J Clin Invest 2008(Dec 1); 118(12): 3917-29. [PubMed Citation]. The last sentence of the Abstract:
Thus, ARHI can induce autophagic cell death, but can also promote tumor dormancy in the presence of factors that promote survival in the cancer microenvironment.
A Commentary: Autophagy-induced tumor dormancy in ovarian cancer by Ravi K Amaravadi, J Clin Invest 2008(Dec 1); 118(12): 3837-40. PubMed Abstract:
Autophagy--a process of "self-eating" that involves enzymatic digestion and recycling of cellular constituents in response to stress--contributes to both cancer cell death and survival. In this issue of the JCI, Lu et al. report that controlled induction of tumor suppressor gene aplasia Ras homolog member I (ARHI) results in autophagic cell death of human ovarian cancer cells in vitro (see the related article beginning on page 3917). However, within xenograft tumors in mice, multiple factors within the tumor microenvironment switched ARHI-induced autophagy to a mechanism of tumor cell survival, leading to tumor dormancy. Since ARHI expression is suppressed in the majority of breast and ovarian cancers but is high in premalignant lesions, ARHI-induced autophagy could be manipulated for therapeutic benefit.
[The JCI publishes all research articles immediately in PubMed Central].

See also: Dormant Cancer Cells Rely on Cellular Self-Cannibalization to Survive, News Release, The University of Texas M. D. Anderson Cancer Center, December 31, 2008.

No comments:

Loading....

Post a Comment